Drug therapy in the management of acute asthma

Archives of Disease in Childhood: Education and Practice Edition

Volumn 92, Issue 3, 2007, Pages

  Carroll, Will ^a,b   Lenney, Warren ^c  

^a Derby Teaching Hospitals NHS FT   (United Kingdom)

^b Ronnie Mac Keith Centre   (United Kingdom)

^c UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMINOPHYLLINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE; IPRATROPIUM BROMIDE; KETAMINE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LEVALBUTEROL; MAGNESIUM SULFATE; MONTELUKAST; PREDNISOLONE; SALBUTAMOL; STEROID; TERBUTALINE; ZAFIRLUKAST;

ARTICLE; ARTIFICIAL VENTILATION; ASTHMA; BRONCHODILATATION; CLINICAL TRIAL; CONTINUOUS INFUSION; DISEASE COURSE; DISEASE EXACERBATION; DRUG EFFICACY; DRUG HALF LIFE; HUMAN; HYPOKALEMIA; INHALATION SPACER; METERED DOSE INHALER; NEBULIZER; OXYGEN THERAPY; PRIORITY JOURNAL; THORAX RADIOGRAPHY; TREATMENT OUTCOME; VOMITING;

ACUTE DISEASE; ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; CHILD; CHILD, PRESCHOOL; CHOLINERGIC ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; LEUKOTRIENE ANTAGONISTS; MAGNESIUM SULFATE; MALE; NEBULIZERS AND VAPORIZERS; STEROIDS; TREATMENT OUTCOME;

EID: 34249830167     PISSN: 17430585     EISSN: 17430593     Source Type: Journal    
DOI: 10.1136/adc.2006.107631     Document Type: Article

References (55)

1. National Asthma Campaign. Out in the open: a true picture of asthma in the United Kingdom today. National Asthma Campaign Audit 2001. Asthma J 2001;6(Suppl):1-14.
2. Office for National Statistics. The health of children and young people. Chapter 7. http://www.statistics.gov.uk/Children/downloads/asthma.pdf (accessed 2 April 2007).
3. Mohan G, Harrison BD, Badminton RM, et al. A confidential enquiry into deaths caused by asthma in an English health region: implications for general practice. Br J Gen Pract 1996;46:529-32.
4. Bucknall CE, Slack R, Godley CC, et al. Scottish Confidential Inquiry into Asthma Deaths (SCIAD), 1994-6. Thorax 1999;54:978-84.
5. Connett GJ, Warde C, Wooler E, et al. Prednisolone and salbutamol in the hospital treatment of acute asthma. Arch Dis Child 1994;70:170-3.
6. Storr J, Barrell E, Barry W, et al. Effect of a single oral dose of prednisolone in acute childhood asthma. Lancet 1987;1:879-82.
7. Lenney W, Alexander J. The management of acute severe asthma. In: Silverman M, eds. Childhood asthma and other wheezing disorders. London: Arnold, 2002:359-75.
8. Cates CJ, Crilly JA, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 2006;(2):CD000052.
9. Dewar AL, Stewart A, Cogswell JJ. A randomised controlled trial to assess the relative benefits of large volume spacers and nebulisers to treat acute asthma in hospital. Arch Dis Child 1999;80:421-3.
10. Benito-Fernandez J, Gonzalez-Balenciaga M, Capape-Zache S, et al. Salbutamol via metered-dose inhaler with spacer versus nebulization for acute treatment of pediatric asthma in the emergency department. Pediatr Emerg Care 2004;20:656-9.
11. Duarte M, Camargos P. Efficacy and safety of a home-made non-valved spacer for bronchodilator therapy in acute asthma. Acta Paediatr 2002;91:909-13.
12. Powell CV, Maskell GR, Marks MK. Successful implementation of spacer treatment guideline for acute asthma. Arch Dis Child 2001;84:142-6.
13. Grove A, McFarlane LC, Lipworth BJ. Expression of the beta 2 adrenoceptor partial agonist/antagonist activity of salbutamol in states of low and high adrenergic tone. Thorax 1995;50:134-8.
14. Moler FW, Hurwitz ME, Custer JR. Improvement in clinical asthma score and PaCO2 in children with severe asthma treated with continuously nebulized terbutaline. J Allergy Clin Immunol 1988;81:1101.
15. Papo MC, Frank J, Thompson AE. A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children. Crit Care Med 1993;21:1479.
16. Rodrigo GJ, Castro-Rodriguez JA. Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with metaanalysis. Thorax 2005;60:740-6.
17. British Thoracic Society/Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax 2003;58(Suppl I):il-i94.
18. Rowe BH, Spooner C, Ducharme FM, et al. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev 2001;(1):CD002178.
19. Rowe BH, Spooner CH, Ducharme FM, et al. Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database Syst Rev 2001;(1):CD000195.
20. Becker JM, Arora A, Scarfone RJ, et al. Oral versus intravenous corticosteroids in children hospitalised with asthma. J Allergy Clin Immunol 1999;103:586-90.
21. Barnett PL, Caputo GL, Baskin M, et al. Intravenous versus oral corticosteroids in the management of acute asthma in children. Ann Emerg Med 1997;29:212-17.
22. Langton Hewer S, Hobbs J, Reid F, et al. Prednisolone in acute childhood asthma: clinical responses to three dosages. Respir Med 1998;92:541-6.
23. Garrett J, Williams S, Wong C, et al. Treatment of acute asthmatic exacerbations with an increased dose of inhaled steroid. Arch Dis Child 1998;79:12-17.
24. FitzGerald JM, Becker A, Sears MR, et al. Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations. Thorax 2004;59:550-6.
25. Harrison TW, Oborne J, Newton S, et al. Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial. Lancet 2004;363:271-5.
26. Schuh S, Reisman J, Alshehri M, et al. A comparison of inhaled fluticasone and oral prednisone for children with acute severe asthma. N Engl J Med 2000;343:689-94.
27. Schuh S, Dick PT, Stephens D, et al. High-dose inhaled fluticasone does not replace oral prednisolone in children with mild to moderate acute asthma. Pediatrics 2006;118:644-50.
28. Rodrigo GJ. Rapid effects of inhaled corticosteroids in acute asthma. Chest 2006;130:1301-11.
29. Bohn D, Kalloghlian A, Jenkins J, et al. Intravenous salbutamol in the treatment of status asthmaticus in children. Crit Care Med 1984;12:892-6.
30. Browne GJ, Penna AS, Phung X, et al. Randomized trial of intravenous salbutamol in early management of acute severe asthma in children. Lancet 1997;349:301-5.
31. Browne GJ, Lam LT. Single-dose intravenous salbutamol bolus for managing children with acute severe asthma in the emergency department: reanalysis of the data. Pediatr Crit Care Med 2002;3:117-23.
32. Browne GJ, Trieu L, Van Asperen P. Randomized, double-blind, placebo controlled trial of intravenous salbutamol and nebulized ipratropium bromide in early management of severe acute asthma in children presenting to an emergency department. Crit Care Med 2002;30:448-53.
33. Sellers WFS, Messahel B. Rapidly repeated intravenous boluses of salbutamol for acute severe asthma. Anaesthesia 2003;58:680-3.
34. Shann F. Intravenous salbutamol. Pediatr Crit Care Med 2003;4:128.
35. Habashi D, Browne GJ, Lam LT. The administration of B2-agonists for paediatric asthma and its adverse reaction in Australian and New Zealand ED. A cross-sectional survey. Eur J Emerg Med 2003;10:174-8.
36. Parr JR, Salama A, Sebire P. A survey of consultant practice: intravenous salbutamol or aminophylline for acute severe childhood asthma and awareness of potential hypokalaemia. Eur J Pediatr 2006;165:323-5.
37. Mitra A, Bassler D, Goodman K, et al. Intravenous aminophylline for acute severe asthma in children over 2 years receiving inhaled bronchodilators. Cochrane Database Syst Rev 2005;(2):CD001276.
38. Roberts G, Newsom D, Gomez K, et al. Intravenous salbutamol bolus compared with an aminophylline infusion in children with severe asthma: a randomised controlled trial. Thorax 2003;58:306-10.
39. Rowe BH, Bretzlaff JA, Bourdon C, et al. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. Cochrane Database Syst Rev 2000,(1):CD001490.
40. Cheuk DKL, Chau TCH, Lee SL. A meta-analysis on intravenous magnesium sulphate for treating acute asthma. Arch Dis Child 2005;90:74-7.
41. Scarfone RJ, Loiselle JM, Joffe MD, et al. A randomised trial of magnesium in the emergency department treatment of children with asthma. Ann Emerg Med 2000;36:572-8.
42. Blitz M, Blitz S, Beasely R, et al. Inhaled magnesium sulphate in the treatment of acute asthma. Cochrane Database Syst Rev 2005;(4):CD003898.
43. Rodrigo GJ, Nannini U. Comparison between nebulized adrenaline and beta-2 agonists for the treatment of acute asthma. A meta-analysis of randomised trials. Am J Emerg Med 2006;24:217-22.
44. Adoun M, Frat JP, Dore P, et al. Comparison of nebulized epinephrine and terbutaline in patients with acute severe asthma: a controlled trial. J Crit Care 2004;19:99-102.
45. Schreck DM, Babin S. Comparison of racemic albuterol and levalbuterol in the treatment of acute asthma in the ED. Am J Emerg Med 2005;23:842-7.
46. Ralston ME, Euwema MS, Knecht KR, et al. Comparison of levalbuterol and racemic albuterol combined with ipratropium bromide in acute pediatric asthma: a randomized controlled trial. J Emerg Med 2005;29:29-35.
47. Weiss JW, Drazen JM, Coles N, et al. Bronchoconstrictor effects of leukotriene C in humans. Science 1982;216:196-8.
48. Laitinen LA, Laitinen A, Haahtela T, et al. Leukotriene E4 and granulocyte infiltration into asthmatic airways. Lancet 1993;341:989-90.
49. Taylor GW, Taylor I, Black P, et al. Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet 1989;1:584-8.
50. Drazen JM, O'Brien J, Sparrow D, et al. Recovery of leukotriene E4 from the urine of patients with airway obstruction. Am Rev Respir Dis 1992;146:104-8.
51. Camargo CA Jr, Smithline HA, Malice MP, et al. A randomised controlled trial of intravenous montelukast in acute asthma. Am J Respir Crit Care Med 2003;167:528-33.
52. Silverman RA, Nowak RM, Korenblat PE, et al. Zafirlukast treatment for acute asthma: evaluation in a randomised, double-blind, multicenter trial. Chest 2004;126:1480-9.
53. Harmanci K, Bakirtas A, Turktas I, et al. Oral montelukast treatment of preschool-aged children with acute asthma. Ann Allergy Asthma Immunol 2006;96:731-5.
54. Meduri GU, Cook TR, Turner RE, et al. Noninvasive positive pressure ventilation in status asthmaticus. Chest 1996;110:767-74.
55. Allen JY, Macias CG. The efficacy of ketamine in pediatric emergency department patients who present with acute severe asthma. Ann Emerg Med 2005;46:43-50.